PER
Click for more information
1.18% 8.4¢ percheron therapeutics limited

Ann: US FDA Feedback on Type C Meeting for ATL1102 in the US, page-153

  1. itsagas
    13,088 Posts.
    lightbulb Created with Sketch. 1366
    clock Created with Sketch.
    10/06/21
    15:57
    Post #: 53772864
    I’ve said all along it’s Alzheimer’s....Tests done on DMD plasma...Anp is very keen on Neuromuscular and Neurodegenerative...diseases.
    Don’t be surprised to see Biogen Partner with Anp for this indication...$$
    Tic Toc ...
    ANP Price at posting: 22.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 23  Upvote
    lightbulb Created with Sketch. 3  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

STN Saturn’s stars have aligned for the gold explorer’s Apollo Project
right-arrow Created with Sketch.
A1M Swagman shoot proves plentiful for AIC, with Cu beyond 3% close to Eloise
right-arrow Created with Sketch.
ARU Cashed up Arafura locks in $171M German export agency deal; locks in NdPr offtake for wind turbines
right-arrow Created with Sketch.
ALK Alkane Resources hit 57.2Kozpa gold production through FY24 – and eyeing 70Ktpa in FY26
right-arrow Created with Sketch.
SXE SCEE boosts Synergy deal by $50M for Collie battery project
right-arrow Created with Sketch.
CUV British study shows Clinuvel drug effective on DNA of UV-damaged skin
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.4¢ 		Change
-0.001(1.18%) 		Mkt cap ! $75.72M
Open High Low Value Volume
8.4¢ 8.4¢ 8.3¢ $3.097K 37.23K

Buyers (Bids)

No. Vol. Price($)
1 29206 8.3¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 118557 1
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.